In 2015, Hugo W. at al reported that up-regulation of gene expression of C-MET, down-regulation of gene expression of LEF1, tumor cell-intrinsic CpG site methylation and YAP1 pathway signature enrichment could be associated with acquired MAPKi resistance [38]. Here, LEF1 is linked to neoplasm.